{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:29:25Z","timestamp":1790659765556,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.semnephrol.2023.151473","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T05:47:00Z","timestamp":1705816020000},"page":"151473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated Coagulation"],"prefix":"10.1016","volume":"43","author":[{"given":"Matthias M.","family":"Engelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Verhamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vanassche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0001","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12882-019-1527-3","article-title":"Renal Association Clinical Practice Guideline on Haemodialysis","volume":"20","author":"Ashby","year":"2019","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0002","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/cc5937","article-title":"Clinical review: Patency of the circuit in continuous renal replacement therapy","volume":"11","author":"Joannidis","year":"2007","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151473_bib0003","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/sdi.13111","article-title":"Basic physics of hemodiafiltration","volume":"35","author":"Pstras","year":"2022","journal-title":"Semin Dial"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0004","article-title":"Biocompatible hemodialysis membranes for acute renal failure","volume":"2008","author":"Alonso","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151473_bib0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/bioengineering8120215","article-title":"Control of blood coagulation by hemocompatible material surfaces\u2014a review","volume":"8","author":"Kuchinka","year":"2021","journal-title":"Bioengineering (Basel)"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0006","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/sdi.12113","article-title":"Hemodialysis and water quality","volume":"26","author":"Coulliette","year":"2013","journal-title":"Semin Dial"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.semvascsurg.2023.04.008","article-title":"Acute problems of hemodialysis access: Thrombosis, aneurysms, symptomatic high-flow fistulas, and complications related to central lines","volume":"36","author":"Franchin","year":"2023","journal-title":"Semin Vasc Surg"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1129729820942040","article-title":"Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation","volume":"22","author":"Jim\u00e9nez Hern\u00e1ndez","year":"2021","journal-title":"J Vasc Access"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00281-011-0288-2","article-title":"The procoagulant and proinflammatory plasma contact system","volume":"34","author":"Renn\u00e9","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"22","key":"10.1016\/j.semnephrol.2023.151473_bib0010","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In vivo roles of factor XII","volume":"120","author":"Renn\u00e9","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2023.151473_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12959-015-0048-y","article-title":"Contact pathway of coagulation and inflammation","volume":"13","author":"Wu","year":"2015","journal-title":"Thromb J"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151473_bib0012","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jacc.2021.06.010","article-title":"Factor XI inhibition to uncouple thrombosis from hemostasis","volume":"78","author":"Hsu","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151473_bib0013","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.hoc.2016.05.007","article-title":"The intrinsic pathway of coagulation as a target for antithrombotic therapy","volume":"30","author":"Wheeler","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151473_bib0014","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1538-7836.2007.02446.x","article-title":"The intrinsic pathway of coagulation: A target for treating thromboembolic disease?","volume":"5","author":"Gailani","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"suppl 2","key":"10.1016\/j.semnephrol.2023.151473_bib0015","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0049-3848(16)30363-2","article-title":"Factor XI and factor XII as targets for new anticoagulants","volume":"141","author":"Weitz","year":"2016","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0016","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5482\/HAMO-14-11-0060","article-title":"New agents for thromboprotection. A role for factor XII and XIIa inhibition","volume":"35","author":"Labberton","year":"2015","journal-title":"Hamostaseologie"},{"issue":"suppl 2","key":"10.1016\/j.semnephrol.2023.151473_bib0017","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(16)30354-1","article-title":"The hemostatic role of factor XI","volume":"141","author":"Puy","year":"2016","journal-title":"Thromb Res"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2023.151473_bib0018","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2516.2000.00053.x","article-title":"Factor XI deficiency and its management","volume":"6","author":"Bolton-Maggs","year":"2000","journal-title":"Haemophilia"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2023.151473_bib0019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","article-title":"Factor XI deficiency in humans","volume":"7","author":"Seligsohn","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151473_bib0020","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","article-title":"Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis","volume":"86","author":"von dem Borne","year":"1995","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0021","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1160\/TH04-04-0250","article-title":"Targeted deletion of murine coagulation factor XII gene\u2014a model for contact phase activation in vivo","volume":"92","author":"Pauer","year":"2004","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0022","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.neuroimage.2009.11.061","article-title":"Enhanced cortical reperfusion protects coagulation factor XII-deficient mice from ischemic stroke as revealed by high-field MRI","volume":"49","author":"Pham","year":"2010","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00109-011-0812-9","article-title":"Blood coagulation factor XII\u2014a neglected player in stroke pathophysiology","volume":"90","author":"Pham","year":"2012","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151473_bib0024","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1538-7836.2010.04031.x","article-title":"Coagulation factor XI as a novel target for antithrombotic treatment","volume":"8","author":"L\u00f6wenberg","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146783","article-title":"The coagulation factor XIIa inhibitor rhainfestin-4 improves outcome after cerebral ischemia\/reperfusion injury in rats","volume":"11","author":"Krupka","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151473_bib0026","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bjh.13990","article-title":"FXIIa inhibitor rHA-infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis","volume":"173","author":"May","year":"2016","journal-title":"Br J Haematol"},{"issue":"222","key":"10.1016\/j.semnephrol.2023.151473_bib0027","doi-asserted-by":"crossref","first-page":"222ra17","DOI":"10.1126\/scitranslmed.3006804","article-title":"A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci Transl Med"},{"issue":"13","key":"10.1016\/j.semnephrol.2023.151473_bib0028","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2013-12-540872","article-title":"Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits","volume":"123","author":"Yau","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151473_bib0029","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/ATVBAHA.114.303315","article-title":"Factor XII regulates the pathological process of thrombus formation on ruptured plaques","volume":"34","author":"Kuijpers","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151473_bib0031","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","article-title":"Factor XII inhibition reduces thrombus formation in a primate thrombosis model","volume":"123","author":"Matafonov","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.semnephrol.2023.151473_bib0032","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0033","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1160\/TH10-05-0307","article-title":"Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis","volume":"105","author":"Salomon","year":"2011","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151473_bib0034","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1182\/blood-2016-09-742262","article-title":"Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events","volume":"129","author":"Preis","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151473_bib0035","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/blood-2007-10-120139","article-title":"Reduced incidence of ischemic stroke in patients with severe factor XI deficiency","volume":"111","author":"Salomon","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0036","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2141.1994.tb04937.x","article-title":"John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia study","volume":"87","author":"Koster","year":"1994","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.semnephrol.2023.151473_bib0037","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","article-title":"Coagulation factors IX through XIII and the risk of future venous thrombosis: The longitudinal investigation of thromboembolism etiology","volume":"114","author":"Cushman","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0038","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: An interface between inflammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0039","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: Pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12016-021-08837-6","article-title":"Blood clotting and the pathogenesis of types I and II hereditary angioedema","volume":"60","author":"de Maat","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151473_bib0041","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.semnephrol.2023.151473_bib0042","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151473_bib0043","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.3390\/ijms22073670","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI): An updated narrative review","volume":"22","author":"Sillen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0044","first-page":"69","article-title":"Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors","volume":"48","author":"Bentounes","year":"2023","journal-title":"J Med Vasc"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151473_bib0045","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jtha.2023.04.021","article-title":"News at XI: Moving beyond factor Xa inhibitors","volume":"21","author":"Fredenburgh","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"22","key":"10.1016\/j.semnephrol.2023.151473_bib0046","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood.2021011725","article-title":"The contact activation inhibitor AB023 in heparin-free hemodialysis: Results of a randomized phase 2 clinical trial","volume":"138","author":"Lorentz","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151473_bib0047","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.kint.2021.08.028","article-title":"Anticoagulation in patients with kidney failure on dialysis: Factor XI as a therapeutic target","volume":"100","author":"Eikelboom","year":"2021","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151473_bib0048","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/psp4.12663","article-title":"PK\/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients","volume":"10","author":"Willmann","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0049","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/107602960200800408","article-title":"Tissue factor and thrombomodulin in hemodialysis patients: Associations with endothelial injury, liver disease, and erythropoietin therapy","volume":"8","author":"Borawski","year":"2002","journal-title":"Clin Appl Thromb Hemost"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151473_bib0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/039139889802101118","article-title":"Tissue factor and tissue factor pathway inhibitor in hemodialysis patients","volume":"21","author":"Yorioka","year":"1998","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.semnephrol.2023.151473_bib0051","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.thromres.2016.05.017","article-title":"Tissue factor expressed by adherent cells contributes to hemodialysis-membrane thrombogenicity","volume":"144","author":"Lakbakbi","year":"2016","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0052","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0035-1564835","article-title":"Platelet physiology","volume":"42","author":"Gremmel","year":"2016","journal-title":"Semin Thromb Hemost."},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151473_bib0053","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10557-022-07366-4","article-title":"Antiplatelet therapy in end-stage renal disease patients on maintenance dialysis: A state-of-the-art review","volume":"37","author":"Ponchia","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0054","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jebm.12235","article-title":"Antithrombotic medications in dialysis patients: A double-edged sword","volume":"10","author":"Vlachopanos","year":"2017","journal-title":"J Evid Based Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imr.13148","article-title":"Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop","volume":"313","author":"Ekdahl","year":"2023","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151473_bib0056","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/aor.13887","article-title":"Complement activation by dialysis membranes and its association with secondary membrane formation and surface charge","volume":"45","author":"Melchior","year":"2021","journal-title":"Artif Organs"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151473_bib0057","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ki.1983.225","article-title":"Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes","volume":"24","author":"Chenoweth","year":"1983","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.semnephrol.2023.151473_bib0058","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.2020007206","article-title":"Complement and the prothrombotic state","volume":"139","author":"Schmidt","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151473_bib0059","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151473_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2018.00071","article-title":"The complement system in dialysis: A forgotten story?","volume":"9","author":"Poppelaars","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151473_bib0061","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40560-014-0066-z","article-title":"Clinical significance of procoagulant microparticles","volume":"3","author":"Nomura","year":"2015","journal-title":"J Intensive Care"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151473_bib0062","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0167-5699(89)90270-3","article-title":"Cytokines as communication signals between leukocytes and endothelial cells","volume":"10","author":"Mantovani","year":"1989","journal-title":"Immunol Today"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151473_bib0063","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2006-03-010322","article-title":"P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor","volume":"108","author":"Pendu","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151473_bib0064","first-page":"1120","article-title":"Leukocyte\u2013platelet aggregates: New particles reflecting and effecting cardiovascular disease","volume":"94","author":"da Costa Martins","year":"2005","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151473_bib0066","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1159\/000510772","article-title":"NET formation in dialysis: A valuable, albeit mysterious and enticing predictor of mortality","volume":"51","author":"Goligorsky","year":"2020","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151473_bib0067","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/ijms23073868","article-title":"Beyond hemostasis: Platelet innate immune interactions and thromboinflammation","volume":"23","author":"Mandel","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151473_bib0068","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: Challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0069","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/09537104.2020.1817360","article-title":"Immunothrombosis and thromboinflammation in host defense and disease","volume":"32","author":"Martinod","year":"2021","journal-title":"Platelets"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151473_bib0070","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0071","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1525-139X.2008.00424.x","article-title":"Pathophysiology and clinical implications of microbubbles during hemodialysis","volume":"21","author":"Barak","year":"2008","journal-title":"Semin Dial"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0072","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/hdi.12474","article-title":"Air contamination during hemodialysis should be minimized","volume":"21","author":"Stegmayr","year":"2017","journal-title":"Hemodial Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151473_bib0073","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1475-097X.2003.00505.x","article-title":"Gas embolism: Pathophysiology and treatment","volume":"23","author":"van Hulst","year":"2003","journal-title":"Clin Physiol Funct Imaging"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0074","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/039139880803100407","article-title":"Hemodialysis dialyzers contribute to contamination of air microemboli that bypass the alarm system in the air trap","volume":"31","author":"Stegmayr","year":"2008","journal-title":"Int J Artif Organs"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151473_bib0075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2215\/CJN.05260516","article-title":"Diagnosis, treatment, and prevention of hemodialysis emergencies","volume":"12","author":"Saha","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151473_bib0076","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/biom11091309","article-title":"Coagulation abnormalities in renal pathology of chronic kidney disease: The interplay between blood cells and soluble factors","volume":"11","author":"Pavlou","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151473_bib0077","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014294","article-title":"Blood coagulation system in patients with chronic kidney disease: A prospective observational study","volume":"7","author":"Huang","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151473_bib0078","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5301\/IJAO.2011.6469","article-title":"Prothrombotic changes in platelet, endothelial and coagulation function following hemodialysis","volume":"34","author":"Milburn","year":"2011","journal-title":"Int J Artif Organs"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0079","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-009-1427-z","article-title":"Inflammation and cachexia in chronic kidney disease","volume":"25","author":"Cheung","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"9617","key":"10.1016\/j.semnephrol.2023.151473_bib0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): A double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151473_bib0081","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: Rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"issue":"suppl 3","key":"10.1016\/j.semnephrol.2023.151473_bib0082","doi-asserted-by":"crossref","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","article-title":"Chronic inflammation in end-stage renal disease and dialysis","volume":"33","author":"Cobo","year":"2018","journal-title":"Nephrol Dial Transplant"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:50:21Z","timestamp":1748357421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0270929523001833"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151473","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated Coagulation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151473"}}